Answer
Yes. Arterial and venous thromboembolic events occurred more often with angiotensin II in its pivotal trial, so preventative measures are normally considered unless contraindicated.
Sources for this answer
- GIAPREZA 2.5 mg/ml concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.